PH

Peyman Hosseinchi

Associate at Ra Ventures

Boston, Massachusetts

Overview 

Peyman Hosseinchi is currently an Associate at RA Ventures in Boston, Massachusetts, with a background in bioengineering and molecular immunology. His notable career highlights include working as an Associate at RA Capital Management, L.P. and serving as a Postdoctoral Scholar and Graduate Research Assistant at the University of Chicago.

Work Experience 

  • Associate

    2023 - Current

    NewCo creation with a focus on therapeutics Responsibilities include ideating new concepts, developing pipeline/corporate strategies, R&D planning, writing investment theses and operational execution

  • Associate

    2021 - 2023

    Working with the investment team to originate conviction in investment opportunities in public and private biotechs developing therapeutics; Advising RA's portfolio companies on their pipeline strategy

RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.

  • Postdoctoral Scholar

    2021 - 2021

  • Graduate Research Assistant

    2016 - 2021

    • Investigated the role of lymphatic vessels in regulating anti-tumor immunity in breast cancer • Contributed to development of various engineered immunotherapies in cancer and autoimmunity

  • Analyst Intern

    2019 - 2020

    Researched competitive companies and underlying markets in the food/peanut allergy space; advised on designing IND-enabling studies

ClostraBio is a biopharma company developing therapeutics for food allergies.

Raised $7,540,000.00 from Portal Innovations.

  • Investment Analyst Intern

    2019 - 2019

ARCH is a venture firm that focuses on life science discoveries to prevent, detect, and cure disease.

  • Technology Venture Associate

    2018 - 2019

    Performed market and competitive analysis for early-stage startups; helped to raise $200K of seed funding for an oncology diagnostic startup

UChicagoTech launched the Innovation Fund in 2010 to accelerate the commercialization of promising.

  • Biotechnology Analyst Intern

    2018 - 2018

    Performed due diligence on public biotechs (small/mid cap) to evaluate investment opportunities in immuno-oncology and rare diseases

Aspire Capital Partners LLC is a Chicago-based investment fund with a focus on making direct investments in publicly traded companies in a

Articles About Peyman

Relevant Websites